2021. Chimeric antigen receptor T‑cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges. Voprosy onkologii. 67, 3 (Jul. 2021), 350–360. DOI:https://doi.org/10.37469/0507-3758-2021-67-3-350-360.